Post-genomics resources and tools for studying apicomplexan metabolism

Trends in Parasitology

Volumn 27, Issue 3, 2011, Pages 131-140

  Hung, Stacy S ^a,b   Parkinson, John ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID METABOLISM; APICOMPLEXA; CARBOHYDRATE METABOLISM; ENERGY METABOLISM; ENZYME ANALYSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; GENOME; LIPID METABOLISM; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE METABOLISM; PHYLOGENETIC TREE; REVIEW;

APICOMPLEXA;

EID: 79952103844     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2010.11.003     Document Type: Review

References (80)

1. Pinney J.W., et al. Metabolic reconstruction and analysis for parasite genomes. Trends Parasitol. 2007, 23:548-554.
2. Feist A.M., Palsson B.O. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat. Biotechnol. 2008, 26:659-667.
3. Reed J.L., Palsson B.O. Thirteen years of building constraint-based in silico models of Escherichia coli. J. Bacteriol. 2003, 185:2692-2699.
4. Herrgard M.J., et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat. Biotechnol. 2008, 26:1155-1160.
5. Thiele I., Palsson B.O. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 2010, 5:93-121.
6. Xu P., et al. The genome of Cryptosporidium hominis. Nature 2004, 431:1107-1112.
7. Gardner M.J., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
8. Abrahamsen M.S., et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 2004, 304:441-445.
9. Carlton J.M., et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002, 419:512-519.
10. Gardner M.J., et al. Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Science 2005, 309:134-137.
11. Pain A., et al. Genome of the host-cell transforming parasite Theileria annulata compared with T. parva. Science 2005, 309:131-133.
12. Pain A., et al. The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 2008, 455:799-803.
13. Brayton K.A., et al. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog. 2007, 3:1401-1413.
14. Seeber F., et al. Apicomplexan mitochondrial metabolism: a story of gains, losses and retentions. Trends Parasitol. 2008, 24:468-478.
15. Anantharaman V., et al. Comparative genomics of protists: new insights into the evolution of eukaryotic signal transduction and gene regulation. Annu. Rev. Microbiol. 2007, 61:453-475.
16. Wasmuth J., et al. The origins of apicomplexan sequence innovation. Genome Res. 2009, 19:1202-1213.
17. Kuo C.H., Kissinger J.C. Consistent and contrasting properties of lineage-specific genes in the apicomplexan parasites Plasmodium and Theileria. BMC Evol. Biol. 2008, 8:108.
18. Ginsburg H. Caveat emptor: limitations of the automated reconstruction of metabolic pathways in Plasmodium. Trends Parasitol. 2009, 25:37-43.
19. Plata G., et al. Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network. Mol. Syst. Biol. 2010, 6:408.
20. Hung S.S., et al. DETECT--a Density Estimation Tool for Enzyme ClassificaTion and its application to Plasmodium falciparum. Bioinformatics 2010, 26:1690-1698.
21. Peregrin-Alvarez J.M., et al. The conservation and evolutionary modularity of metabolism. Genome Biol. 2009, 10:R63.
22. Altschul S.F., et al. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
23. Claudel-Renard C., et al. Enzyme-specific profiles for genome annotation: PRIAM. Nucleic Acids Res. 2003, 31:6633-6639.
24. Pinney J.W., et al. metaSHARK: software for automated metabolic network prediction from DNA sequence and its application to the genomes of Plasmodium falciparum and Eimeria tenella. Nucleic Acids Res. 2005, 33:1399-1409.
25. Whitaker J.W., et al. Alio intuitu: the automated reconstruction of the metabolic networks of parasites. Trends Parasitol. 2009, 25:396-397.
26. Bzik D.J., et al. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:8360-8364.
27. Ling Y., et al. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates. J. Biol. Chem. 2007, 282:30804-30816.
28. Arakaki A.K., et al. EFICAz2: enzyme function inference by a combined approach enhanced by machine learning. BMC Bioinform. 2009, 10:107.
29. Caspi R., et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2010, 38:D473-479.
30. Karp P.D., et al. Pathway Tools version 13.0: integrated software for pathway/genome informatics and systems biology. Brief Bioinform. 2009, 11:40-79.
31. Caspi R., et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res. 2006, 34:D511-516.
32. Kanehisa M., et al. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38:D355-360.
33. Aurrecoechea C., et al. EuPathDB: a portal to eukaryotic pathogen databases. Nucleic Acids Res. 2009, 38:D415-419.
34. Chen F., et al. OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res. 2006, 34:D363-368.
35. Ginsburg H. Progress in in silico functional genomics: the malaria Metabolic Pathways database. Trends Parasitol. 2006, 22:238-240.
36. Chang A., et al. BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009. Nucleic Acids Res. 2009, 37:D588-592.
37. Keithly J.S., et al. Electron tomographic and ultrastructural analysis of the Cryptosporidium parvum relict mitochondrion, its associated membranes, and organelles. J. Eukaryot. Microbiol. 2005, 52:132-140.
38. Mogi T., Kita K. Diversity in mitochondrial metabolic pathways in parasitic protists Plasmodium and Cryptosporidium. Parasitol. Int. 2010, 59:305-312.
39. Mather M.W., et al. Mitochondrial drug targets in apicomplexan parasites. Curr. Drug Targets 2007, 8:49-60.
40. Escalante A.A., et al. The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum. Trends Parasitol. 2009, 25:557-563.
41. Krungkrai J., et al. De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol. Biochem. Parasitol. 1989, 32:25-37.
42. Knockel J., et al. The apicomplexan parasite Toxoplasma gondii generates pyridoxal phosphate de novo. Mol. Biochem. Parasitol. 2007, 152:108-111.
43. Wrenger C., et al. Vitamin B1 de novo synthesis in the human malaria parasite Plasmodium falciparum depends on external provision of 4-amino-5-hydroxymethyl-2-methylpyrimidine. Biol. Chem. 2006, 387:41-51.
44. Gengenbacher M., et al. Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. J. Biol. Chem. 2006, 281:3633-3641.
45. Chaudhary K., Roos D.S. Protozoan genomics for drug discovery. Nat. Biotechnol. 2005, 23:1089-1091.
46. Green M.L., Karp P.D. The outcomes of pathway database computations depend on pathway ontology. Nucleic Acids Res. 2006, 34:3687-3697.
47. Olszewski K.L., et al. Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 2010, 466:774-778.
48. Forst C.V. Host-pathogen systems biology. Drug Discov. Today 2006, 11:220-227.
49. Nerima B., et al. Comparative genomics of metabolic networks of free-living and parasitic eukaryotes. BMC Genomics 2010, 11:217.
50. Yeh I., et al. Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res. 2004, 14:917-924.
51. Kim T.Y., et al. Metabolite-centric approaches for the discovery of antibacterials using genome-scale metabolic networks. Metab. Eng. 2010, 12:105-111.
52. Oberhardt M.A., et al. Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol. 2009, 5:320.
53. Orth J.D., et al. What is flux balance analysis?. Nat. Biotechnol. 2010, 28:245-248.
54. Vanee N., et al. A genome-scale metabolic model of Cryptosporidium hominis. Chem. Biodivers 2010, 7:1026-1039.
55. McConkey G.A., et al. Annotating the Plasmodium genome and the enigma of the shikimate pathway. Trends Parasitol. 2004, 20:60-65.
56. Goodman C.D., McFadden G.I. Fatty acid synthesis in protozoan parasites: unusual pathways and novel drug targets. Curr. Pharm. Des. 2008, 14:901-916.
57. Moreno S.N., Li Z.H. Anti-infectives targeting the isoprenoid pathway of Toxoplasma gondii. Expert Opin. Ther. Targets 2008, 12:253-263.
58. Perkins S.L., et al. The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes. Infect Genet. Evol. 2007, 7:74-83.
59. Zhu G., et al. What is the phylogenetic position of Cryptosporidium?. Int. J. Syst. Evol. Microbiol. 2000, 50(Pt 4):1673-1681.
60. Green M.L., Karp P.D. A Bayesian method for identifying missing enzymes in predicted metabolic pathway databases. BMC Bioinform. 2004, 5:76.
61. Chen L., Vitkup D. Predicting genes for orphan metabolic activities using phylogenetic profiles. Genome Biol. 2006, 7:R17.
62. Lee J.M., Sonnhammer E.L. Genomic gene clustering analysis of pathways in eukaryotes. Genome Res. 2003, 13:875-882.
63. Suhre K. Inference of gene function based on gene fusion events: the rosetta-stone method. Methods Mol. Biol. 2007, 396:31-41.
64. Zhou Y., et al. Evidence-based annotation of the malaria parasite's genome using comparative expression profiling. PLoS One 2008, 3:e1570.
65. Bozdech Z., et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 2003, 1:E5.
66. Kalisiak J., et al. Identification of a new endogenous metabolite and the characterization of its protein interactions through an immobilization approach. J. Am. Chem. Soc. 2009, 131:378-386.
67. Kafsack B.F., Llinas M. Eating at the table of another: metabolomics of host-parasite interactions. Cell Host Microbe 2010, 7:90-99.
68. Dittrich S., et al. An atypical orthologue of 6-pyruvoyltetrahydropterin synthase can provide the missing link in the folate biosynthesis pathway of malaria parasites. Mol. Microbiol. 2008, 67:609-618.
69. Aboge G.O., et al. Cloning, expression, and characterization of Babesia gibsoni dihydrofolate reductase-thymidylate synthase: inhibitory effect of antifolates on its catalytic activity and parasite proliferation. Antimicrob. Agents Chemother. 2008, 52:4072-4080.
70. Anderson A.C. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2005, 61:258-262.
71. Yuthavong Y., et al. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors. Parasitology 2005, 130:249-259.
72. Manichaikul A., et al. Metabolic network analysis integrated with transcript verification for sequenced genomes. Nat. Methods 2009, 6:589-592.
73. Raman K., Chandra N. Flux balance analysis of biological systems: applications and challenges. Brief Bioinform. 2009, bbp011.
74. Lee J.M., et al. Flux balance analysis in the era of metabolomics. Brief Bioinform. 2006, 7:140-150.
75. Kauffman K.J., et al. Advances in flux balance analysis. Curr. Opin. Biotech. 2003, 14:491-496.
76. Huthmacher C., et al. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst. Biol. 2010, 4:120.
77. Liu J., et al. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:8840-8845.
78. Chavali A.K., et al. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol. Syst. Biol. 2008, 4.
79. Colijn C., et al. Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput. Biol. 2009, 5:e1000489.
80. Raman K., et al. Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs. PLoS Comput. Biol. 2005, 1:e46.